VITASPRING BIOMEDICAL CO., LTD. (VSBC) Free cash flow 2022–2023
VITASPRING BIOMEDICAL CO., LTD. (VSBC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$77,556FY2023 · since FY2022: -$342,628 → -$77,556
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$77,556 | +77.4% |
| FY2022 | -$342,628 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net incomeVSBC Net marginVSBC Gross profitVSBC Gross marginVSBC Operating incomeVSBC Operating marginVSBC Operating cash flowVSBC Capital expendituresVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →